X4 Pharmaceuticals XFOR
NASDAQ XFOR
$3.01 -0.01 (-0.33%)
At close: Oct 21, 2026 · 4:00 PM EDT

X4 Pharmaceuticals (XFOR) Operating Expenses (2017 - 2026)

Updated

X4 Pharmaceuticals' Operating Expenses was $23.58 million in Q2 2026, down 15.4% from $27.88 million a year earlier but up 5.2% from the prior quarter.

Analysis

X4 Pharmaceuticals (XFOR) Operating Expenses (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, X4 Pharmaceuticals' Operating Expenses was $100.82 million through Jun 30, 2026, down 24.2% year-over-year; for FY2025, it came in at $116.24 million, up 198.4% from FY2024.

  • Operating Expenses shows a five-year compound annual growth rate of 13.1% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $38.96 million in FY2024 (-63.8%), $107.52 million in FY2023 (+22.8%), $87.57 million in FY2022 (+2.9%) and $85.11 million in FY2021 (+35.4%).
  • Quarterly Operating Expenses has moved between $19.12 million (Q3 2021) and $37.29 million (Q1 2024) over five years.
  • Compared with a year earlier, Operating Expenses has declined for six straight quarters, with an average decline of 6.2% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q4 2021 (growth of 64.6%); the worst was Q1 2026 (a decline of 33.2%).
  • Per Business Quant data, XFOR's Operating Expenses in the three quarters before Q2 2026 was $22.42 million (Q1 2026), $25.9 million (Q4 2025) and $28.92 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 10.12 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 10.56 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 9.70 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 18.20 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 6.68 Bn
10 X4 Pharmaceuticals 379.03 Mn -319.65 Mn 7.19 Mn 23.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.58 Mn
Mar 31, 2026 22.42 Mn
Dec 31, 2025 25.90 Mn
Sep 30, 2025 28.92 Mn
Jun 30, 2025 27.88 Mn
Mar 31, 2025 33.53 Mn
Dec 31, 2024 36.85 Mn
Sep 30, 2024 34.83 Mn
Jun 30, 2024 34.19 Mn
Mar 31, 2024 37.29 Mn
Dec 31, 2023 25.20 Mn
Sep 30, 2023 27.21 Mn
Jun 30, 2023 25.81 Mn
Mar 31, 2023 29.30 Mn
Dec 31, 2022 25.58 Mn
Sep 30, 2022 20.15 Mn
Jun 30, 2022 20.57 Mn
Mar 31, 2022 21.27 Mn
Dec 31, 2021 29.06 Mn
Sep 30, 2021 19.12 Mn
API Access

X4 Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=XFOR&period=max&api_key=YOUR_API_KEY